Cutting-edge all-in-one drug abuse rapid test reagent - Taiwan Registration 0e2528192c8a7bb2c7d2fa934ae88c6c
Access comprehensive regulatory information for Cutting-edge all-in-one drug abuse rapid test reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 0e2528192c8a7bb2c7d2fa934ae88c6c and manufactured by Formosa Biomedical Technology Co., Ltd. Yilan Factory. The authorized representative in Taiwan is TAIWAN ADVANCE BIO-PHARMACEUTICAL INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
This product is used by competitive immunochromatography to qualitatively detect morphine (MOP), amphetamine (AMP), methamphetamine (MET), ecstasy (MDMA), kaitamine (KET), cannabis (THC), cocaine (COC), benzodiazepines (nitropine OXA/flunazepam FM2/one capsule NTZ), spicy cannabis (K2) metabolites (JWH-018 and JWH-073) in human urine. The test results can be used as initial screening with morphine positive thresholds of 300 ng/ml, amphetamine positive threshold of 1000 ng/ml, methamphetamine positive threshold of 500 ng/ml, ecstasy positive threshold of 500 ng/ml, katamine positive threshold of 100 ng/ml, cannabis positive threshold of 50 ng/ml, cocaine positive threshold of 300 ng/ml, benzodiazepine positive threshold of 300 ng/ml, flunazepam 400 ng/ ml, one capsule 100 ng/ml, spicy cannabis metabolites (JWH-018 and JWH-073) positive threshold was 50 ng/ml. This product can be used by both individuals and professionals.
A Clinical chemistry and clinical toxicology
A.0001 ่ฏ็ฐๅฉๅฎ่ฉฆ้ฉ็ณป็ตฑ
Domestic;; Contract manufacturing
Dates and Status
Oct 23, 2018
Dec 06, 2022
Apr 12, 2024
Cancellation Information
Logged out
่จฑๅฏ่ญๅทฒ้พๆๆๆ